MDA-MB-231, which belongs to the basal-like subtype, is a highly aggressive, invasive, poorly differentiated triple-negative breast cancer (TNBC) cell line due to its lack of ER, PR, and HER2, and is known for its resistance to anti-cancer therapies [19,20]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.